Legal

J&J's Third Talc Bankruptcy Dismissed: What the Red River Ruling Means for the Talc Litigation Landscape

On March 31, 2025, Judge Lopez dismissed J&J's Red River Talc Chapter 11 under the Third Circuit's good-faith standard, returning 67,115 cases to MDL 2738.

Rod De Llano
Rod De Llano Founding Partner at Danziger & De Llano, Princeton graduate Contact Rod
| | 12 min read

On March 31, 2025, U.S. Bankruptcy Judge Christopher Lopez dismissed Red River Talc LLC's Chapter 11 case — the third time federal courts have rejected Johnson & Johnson's effort to use bankruptcy to cap talc liability.[3] With the U.S. Supreme Court declining to intervene and J&J announcing it will not appeal, the 67,115 plaintiffs whose cases were stayed in MDL 2738 are now back in the tort system — alongside thousands of newly diagnosed mesothelioma claimants whose filings were paused during the Chapter 11 freeze.[4] Call (855) 699-5441 for a free, no-obligation review of how the post-dismissal landscape applies to a specific case.

Executive Summary

Johnson & Johnson's third Texas Two-Step bankruptcy attempt — the Red River Talc filing in the Southern District of Texas — was dismissed by Judge Christopher Lopez on March 31, 2025. The ruling followed the same good-faith reasoning the Third Circuit applied to dismiss J&J's earlier LTL Management filings. Approximately 67,115 talcum powder lawsuits in MDL 2738 had been frozen during the bankruptcy and resumed activity in April 2025. The standard post-dismissal posture for active plaintiffs is renewed case-management activity, refreshed medical and exposure documentation, and accelerated discovery in MDL 2738 in the District of New Jersey. Newly diagnosed talc-related mesothelioma claimants have access to multiple parallel channels: individual product liability lawsuits, asbestos trust fund claims through the forming Imerys Talc America trust, and trust filings against bankrupt asbestos companies whose schedules cover talc exposure (over $30 billion in active asbestos trusts overall). With $2.5 billion in 2025 talc verdicts and a $1.5 billion single-plaintiff award in Baltimore, the financial pressure on J&J continues to mount despite the company's stated intent to defend each case in tort. The 93,000 figure that has appeared in some media coverage refers to the broader settlement voting pool from the prior LTL bankruptcy phase, not to currently pending plaintiffs — the operative pending number is 67,115 in MDL 2738.

67,115

Pending lawsuits in MDL 2738 affected by the dismissal

3

Consecutive J&J talc bankruptcies dismissed (2023, 2023, 2025)

$2.5 Billion+

Total talc verdicts awarded in 2025 alone

$1.5 Billion

Largest single-plaintiff verdict (Craft v. J&J, Baltimore, Dec. 2025)

What Are the Key Facts About the Red River Talc Dismissal?

  • March 31, 2025 dismissal: Judge Christopher Lopez of the U.S. Bankruptcy Court for the Southern District of Texas dismissed Red River Talc LLC's Chapter 11 case (No. 24-90505) on good-faith grounds.[3]
  • Third consecutive failure: Federal courts have now rejected J&J's bankruptcy strategy three times — LTL Management I (dismissed by the Third Circuit in January 2023), LTL Management II (withdrawn in December 2023 after the Third Circuit signaled rejection), and Red River Talc (dismissed March 2025).
  • Supreme Court declined review: The U.S. Supreme Court refused to hear J&J's appeal of the dismissal, leaving the precedent in place.
  • 67,115 pending plaintiffs: The MDL 2738 docket before Judge Michael Shipp in the District of New Jersey held approximately 67,115 cases as of March 2026.[4]
  • $8 billion proposed fund rejected: J&J had proposed an $8 billion settlement fund through Red River Talc to resolve current and future ovarian cancer claims; mesothelioma claims were excluded from the bankruptcy plan and continued in tort.
  • $2.5 billion in 2025 verdicts: Despite the failed bankruptcy, juries awarded record-breaking talc verdicts including $1.5 billion in Baltimore (Craft v. J&J), $966 million in Los Angeles (Moore v. J&J), $65.5 million in Minnesota, $42 million in Boston, and $40 million in Los Angeles (Kent & Schultz v. J&J).
  • J&J reserves of $7-9 billion: The company has set aside approximately $7 to $9 billion for talc liability, signaling a defensive litigation posture rather than a single global resolution.
  • MDL resumed in April 2025: Judge Shipp's docket lifted most stays in April 2025 after the bankruptcy was dismissed, allowing case-management activity to resume across the 67,115 pending matters.
  • Imerys trust in formation: Imerys Talc America, the world's largest talc supplier and J&J's longtime supplier, is establishing an asbestos trust through its own bankruptcy — a separate compensation channel for eligible plaintiffs.
  • Statutes of limitations vary by state: Most states begin the clock at diagnosis or discovery; the typical window is one to six years after diagnosis, which is why time is a structural factor in the post-dismissal landscape.

Why Did Judge Lopez Dismiss the Red River Talc Bankruptcy?

The dismissal turned on a single legal concept that has now defeated J&J's strategy three consecutive times: good faith. Chapter 11 of the U.S. Bankruptcy Code requires that a filing be made for a legitimate reorganization purpose, not as a tactical maneuver to gain leverage that the petitioner could not obtain in court.[1]

"Judge Lopez looked at the same facts the Third Circuit had already evaluated and reached the same conclusion. Johnson & Johnson is one of the most profitable corporations on the planet. It does not need bankruptcy protection. Creating a shell subsidiary, loading it with $80 billion of liability, and filing that subsidiary for Chapter 11 is not a good-faith reorganization — it is litigation strategy dressed in bankruptcy clothing."

— Rod De Llano, Founding Partner, Danziger & De Llano

The Texas Two-Step mechanic. J&J used the divisive merger procedure available under Chapter 10 of the Texas Business Organizations Code — the chapter governing mergers, interest exchanges, and conversions — to divide a single corporation into two entities, with the new shell subsidiary taking the talc tort liabilities and then filing for bankruptcy in a favorable jurisdiction. The strategy was designed to invoke Section 524 of the U.S. Bankruptcy Code, which addresses the effect of discharge in bankruptcy and includes the special asbestos-trust provisions in subsection (g).[1]

Why Section 524(g) did not fit J&J. Section 524(g) is a special bankruptcy provision for asbestos cases, designed to be used in genuine reorganization proceedings where the debtor cannot pay its claims. J&J had over $80 billion in annual revenue at the time of each filing. Federal courts have now ruled three times that a solvent parent cannot use a divisive merger to manufacture an insolvent subsidiary purely to access this statute. For broader background, see the firm's analysis of all three failed attempts.

Supreme Court declined to revisit. The Supreme Court's refusal to grant certiorari closed the appellate door for this round. Combined with three consecutive lower-court rejections, the precedent is now settled: bankruptcy is not a viable cap on J&J talc liability.

What Does the Dismissal Mean for the 67,000 MDL 2738 Plaintiffs?

Plaintiffs whose cases were filed before the bankruptcy — the vast majority of the 67,115 pending in MDL 2738 in the District of New Jersey — saw most pretrial activity paused while Red River Talc's Chapter 11 worked through the Texas court.[4] With the dismissal, Judge Michael Shipp's docket resumed activity in April 2025, and case management is accelerating.

"For pending plaintiffs, the practical impact is that discovery, depositions, and bellwether trials are moving again. Cases that were filed a year ago and went silent during the bankruptcy freeze are now back in active case-management. The standard step at this point is for counsel to refresh medical records, update exposure documentation, and confirm contact information."

— Rod De Llano, Founding Partner, Danziger & De Llano

What case-management typically looks like after a Chapter 11 lift in MDL 2738:

  • Active plaintiffs and their counsel verify case status in MDL 2738 and reconfirm contact information after the docket reopened in April 2025.
  • Medical records are refreshed, including current pathology, imaging, and treatment summaries. Cases that have moved through chemotherapy, immunotherapy, or surgery during the freeze typically need updated documentation before trial-ready posture is restored.
  • Deceased-plaintiff status is documented promptly — survival actions and wrongful death claims have separate procedural timelines that the MDL applies independently.
  • Product packaging, photographs, receipts, and witness statements that establish the talc exposure history are preserved as part of the standard MDL file refresh.
  • Counsel evaluates whether a case is a candidate for a bellwether trial slot or for any direct negotiation track J&J may open as it litigates individual cases in the tort system.

What Does the Dismissal Mean for Newly Diagnosed Talc Mesothelioma Claimants?

The dismissal of Red River Talc removed the procedural barrier that had paused many talc filings during the Chapter 11 freeze. Individual cases can now move forward in state and federal courts, and trust fund claim channels remain open through Imerys Talc America's bankruptcy and the broader asbestos trust system.

"Diagnostic dates trigger statutes of limitations in every state. The post-dismissal landscape removes the bankruptcy-related delay, which means time is now the structural factor — not corporate procedural maneuvering. The company is litigating case by case, and the operative compensation pathways are the tort system, the Imerys trust, and the broader asbestos trust universe running in parallel."

— Rod De Llano, Founding Partner, Danziger & De Llano

What the standard intake looks like for a newly diagnosed talc-related mesothelioma claimant:

  • Pathology report confirming mesothelioma (pleural or peritoneal) and any cytology slides or tissue blocks form the medical foundation of the claim.
  • A consumer-product history is catalogued — baby powder, body powder, dry shampoo, cosmetic powder, foot powder — including approximate dates and frequency of use, drawn from the claimant's own recollection and household corroboration.
  • Household members who may provide take-home or secondary exposure documentation are identified during the intake interview.
  • Employment records are pulled to rule out occupational asbestos exposures or, more commonly, to document concurrent exposure pathways that may support trust fund claims against multiple bankrupt manufacturers.
  • Consultation with a mesothelioma attorney within weeks rather than months of diagnosis is standard practice given that statute deadlines vary from one to six years and run from diagnosis or discovery.

Newly diagnosed claimants typically have access to multiple recovery channels operating in parallel: a trust fund claim against bankrupt asbestos defendants, an individual product liability lawsuit against J&J and other talc defendants, and possibly a workers' compensation or veterans' disability claim if occupational exposure is also documented.[13]

How Are 2025 and 2026 Verdicts Reshaping the Tort System Path?

J&J's stated strategy after Judge Lopez's dismissal — "return to the tort system to litigate and defeat these meritless talc claims" — has been tested in trial after trial. The 2025 verdict trajectory does not support the company's position, and a $2 billion Missouri verdict has been widely cited as a significant motivating factor in J&J's announced no-appeal, no-refile posture.

  • December 2025 — $1.5 billion (Baltimore, MD). Craft v. J&J set the record for the largest single-plaintiff talc verdict, with $59.8 million in compensatory damages and $1.5 billion in punitive damages for a peritoneal mesothelioma plaintiff.
  • October 2025 — $966 million (Los Angeles, CA). Moore v. J&J, a mesothelioma wrongful death case, produced $16 million in compensatory damages and $950 million in punitive damages.
  • December 2025 — $65.5 million (Minnesota). A mesothelioma verdict demonstrating that high awards extend beyond traditional plaintiff-friendly venues.
  • July 2025 — $42 million (Boston, MA). Mesothelioma verdict during the post-bankruptcy litigation surge.
  • December 2025 — $40 million (Los Angeles, CA). Kent & Schultz v. J&J ovarian cancer verdict.

Cumulatively, 2024 produced over $320 million in mesothelioma-related talc verdicts, and 2025 exceeded $2.5 billion across all talc verdict types. Federal jury verdicts have continued through early 2026, with multimillion-dollar awards becoming routine rather than exceptional. The firm's 2025 verdict review covers the punitive-to-compensatory ratios that are driving these awards.

Where Do Asbestos Trust Funds Fit After the J&J Bankruptcy Failure?

The failure of the J&J bankruptcy does not mean the asbestos trust fund system is unavailable to talc claimants — it just means J&J itself is not establishing one through Section 524(g). Other channels remain.[13]

"A talc plaintiff with mesothelioma usually has more than one viable claim. The Imerys trust is forming, other bankrupt asbestos companies in the broader trust system have paid talc-related claims when contaminated talc was a documented exposure, and the individual lawsuit against J&J runs in parallel. The standard practice is to file every channel a claimant is eligible for — nothing is mutually exclusive."

— Rod De Llano, Founding Partner, Danziger & De Llano

Imerys Talc America trust. Imerys, the world's largest talc supplier and J&J's longtime supplier, is establishing a trust through its own Chapter 11 case. The U.S. District Court for the District of Delaware affirmed the Bankruptcy Court's order in 2025. Eligible mesothelioma plaintiffs whose exposure included Imerys-supplied talc are filing claims through that trust process.

Section 524(g) trusts elsewhere in the system. The broader asbestos trust system holds more than $30 billion across more than 60 active asbestos trust funds. Many trust schedules pay claims when talc exposure was documented as part of the exposure history, even when the trust itself was not specifically a talc trust.

Trusts and lawsuits run in parallel. Trust fund claims do not bar individual lawsuits, and most state laws require disclosure of trust filings during civil discovery. Experienced counsel files trust claims and litigation simultaneously to maximize recovery.

Why Does the FDA Testing Withdrawal Increase the Importance of Litigation?

In December 2024, the FDA proposed a rule under the Modernization of Cosmetics Regulation Act that would have required mandatory asbestos testing for all talc-containing cosmetic products using polarized light microscopy and transmission electron microscopy. One year later, in December 2025, the rule was officially withdrawn, leaving cosmetic talc testing voluntary.

The FDA itself has documented finding asbestos in cosmetic talc samples in its survey testing of cosmetic products containing talc. The agency has long acknowledged that asbestos and talc occur together in geological deposits. The withdrawal of the proposed rule did not change those underlying scientific realities — it changed only the regulatory response to them.

With no federal mandatory testing requirement in place, civil litigation is now the primary mechanism that creates accountability for asbestos contamination in talc products. Each verdict and settlement records a corporate cost for inadequate testing — a function regulators are not, as of 2026, performing.

What Is the Practical Path Forward in the Post-Dismissal Talc Landscape?

Whether a case is among the 67,115 already in MDL 2738 or is a new claim that has not yet been filed, the bankruptcy dismissal clarifies the path forward. There is no global settlement coming through a Section 524(g) trust. The operative compensation channels are the tort system, the Imerys trust, and the broader asbestos trust system — all of which are moving.

For a same-day assessment of a potential claim, the firm offers a free case evaluation quiz, or callers can reach Danziger & De Llano directly at (855) 699-5441 for a confidential consultation. Background reading: talc-related mesothelioma compensation and the firm's 90,000-lawsuit mass tort overview.

Statutes of limitations are running across all 50 states. Cases are handled on contingency — no fees unless recovery is achieved.

Frequently Asked Questions

What happened with Johnson & Johnson's third talc bankruptcy attempt?

On March 31, 2025, U.S. Bankruptcy Judge Christopher Lopez of the Southern District of Texas dismissed Red River Talc LLC's Chapter 11 case (No. 24-90505), finding that the filing failed the good-faith requirement under Third Circuit precedent. Red River Talc was Johnson & Johnson's third subsidiary created to absorb talc liabilities and seek bankruptcy protection. J&J announced it would not appeal and would return to the tort system. The U.S. Supreme Court declined to intervene, leaving the dismissal in place.

How many pending talc plaintiffs are affected by the dismissal?

Approximately 67,115 talcum powder lawsuits remained pending in MDL 2738 in the District of New Jersey before Judge Michael Shipp as of March 2026. The MDL had been largely frozen during the bankruptcy proceedings and resumed activity in April 2025 after Judge Lopez's dismissal. With the bankruptcy strategy defeated, those 67,115 cases are now proceeding through the tort system rather than being channeled into a capped trust.

What is the practical posture for MDL 2738 plaintiffs after the dismissal?

Plaintiffs whose cases were stayed during the bankruptcy are seeing renewed activity in MDL 2738 as Judge Shipp's docket reopened in April 2025. The standard posture in this phase is for active plaintiffs to verify case status with counsel, refresh medical records and exposure documentation, and prepare for accelerated discovery and bellwether designations. The MDL is now moving through the case-management activity that was paused during the Chapter 11 freeze.

Can a newly diagnosed talc-related mesothelioma plaintiff still file a claim after the bankruptcy dismissal?

Yes. The dismissal of Red River Talc removed the procedural barrier that had paused many talc filings during the Chapter 11 freeze. Individual lawsuits can now proceed in state and federal courts, and trust fund claim channels remain open through Imerys Talc America's bankruptcy and the broader asbestos trust system. Statutes of limitations vary by state and typically begin from the date of diagnosis or the date the connection between exposure and disease is discovered, which is why time is a structural factor in the post-dismissal landscape.

Why did Judge Lopez reject Red River Talc's bankruptcy?

Judge Lopez ruled that the Red River Talc filing failed the good-faith requirement that Chapter 11 of the Bankruptcy Code requires. The court found that Johnson & Johnson, the parent company, was financially healthy with over $80 billion in annual revenue and used the divisive merger statute under Texas law to create Red River Talc solely to obtain bankruptcy protections that J&J itself could not directly access. The ruling followed the Third Circuit's earlier reasoning in dismissing the LTL Management cases, which established that solvent parents cannot use shell subsidiaries to invoke Section 524(g) of the Bankruptcy Code.

What is Section 524(g) and why did J&J want to use it?

Section 524(g) of the U.S. Bankruptcy Code is a special asbestos-trust provision that lets a bankruptcy court issue a channeling injunction directing all current and future asbestos claims into a dedicated trust, permanently shielding the reorganized company from further litigation. Congress enacted Section 524(g) in 1994 to address genuinely insolvent asbestos companies modeled on the Johns-Manville bankruptcy. Johnson & Johnson tried to use this provision by creating shell subsidiaries loaded with talc liabilities and filing those entities for bankruptcy. Three federal courts ruled this was an improper use of a statute designed for actual insolvency.

What do recent verdicts indicate about talc recovery values in the post-bankruptcy tort system?

Recovery values vary widely depending on cancer type, evidence strength, and jurisdiction. Legal analysts have estimated the average individual talc settlement at approximately $500,000, though mesothelioma cases tend to command higher amounts than ovarian cancer cases. Verdicts in 2025 ranged from $8 million in Suffolk County, Massachusetts to $1.5 billion in the Craft v. J&J Baltimore case, with total 2025 talc verdicts exceeding $2.5 billion across all categories. These numbers describe the litigation landscape rather than predict any individual outcome.

Are talc trust funds available outside the failed J&J bankruptcy?

Yes. Imerys Talc America, the world's largest talc supplier and the company that supplied talc to Johnson & Johnson and other manufacturers, filed for Chapter 11 bankruptcy and is establishing a trust to address its talc-related liabilities. The U.S. District Court for the District of Delaware affirmed the Bankruptcy Court's order in the Imerys case in 2025. Other bankrupt asbestos companies in the broader asbestos trust system also pay claims when contaminated talc is a documented exposure source. With more than $30 billion held across active asbestos trusts, eligible mesothelioma plaintiffs may file trust claims concurrently with personal injury lawsuits.

Could Johnson & Johnson try a fourth bankruptcy?

While there is no absolute legal bar against another filing, three consecutive failures and the Supreme Court's refusal to intervene have established strong precedent against this approach for J&J specifically. Legal analysts widely treat the Texas Two-Step as a closed avenue. Johnson & Johnson announced publicly that it will not appeal or refile another bankruptcy case and that it will return to the tort system and litigate cases individually. The company's reserves of approximately $7 to $9 billion for talc liability are consistent with a long-term defensive litigation posture rather than a fresh bankruptcy attempt.

References

  1. 11 U.S.C. § 524 - Effect of discharge (including Section 524(g)) — law.cornell.edu
  2. Texas Business Organizations Code, Chapter 10 - Mergers, Interest Exchanges, and Conversions — statutes.capitol.texas.gov
  3. U.S. Bankruptcy Court for the Southern District of Texas — txs.uscourts.gov
  4. U.S. Judicial Panel on Multidistrict Litigation - Pending MDLs (MDL 2738) — jpml.uscourts.gov
  5. FDA - Talc in Cosmetics — fda.gov
  6. ATSDR Toxicological Profile for Asbestos — atsdr.cdc.gov
  7. NCI - Asbestos Exposure and Cancer Risk Fact Sheet — cancer.gov
  8. OSHA - Asbestos Standard for the Construction Industry (29 CFR 1926.1101) — osha.gov
  9. NCI - Mesothelioma Patient Information — cancer.gov
  10. USGS - Talc and Pyrophyllite Statistics and Information — usgs.gov
  11. Section 524(g) Bankruptcy Trusts - WikiMesothelioma — wikimesothelioma.com
  12. Mesothelioma Claim Process - WikiMesothelioma — wikimesothelioma.com
  13. Asbestos Trust Funds - WikiMesothelioma — wikimesothelioma.com

Related Articles

Rod De Llano

About the Author

Rod De Llano

Founding Partner at Danziger & De Llano, Princeton graduate with corporate defense background

Need Help With Your Case?

If you or a loved one has been diagnosed with mesothelioma, our experienced attorneys can help you understand your options and pursue the compensation you deserve.